Health And Medicine

Researchers at Vanderbilt University Medical Center have discovered why the uropathogenic bacterium E. coli, the leading cause of urinary tract infections, is so tenacious; their findings could lead to new ways to prevent recurrent UTIs. Read More

Dr. James Crowe, Robert Carnahan and their colleagues in the Vanderbilt Vaccine Center won the Gold medal in the 2022 R&D 100 awards for their discovery and development of long-acting antibodies that protect against COVID-19. The discovery of these antibodies has led to the development of Evusheld, pre-exposure therapy to prevent COVID-19 for adults and children over 12 with compromised immune systems or a history of severe adverse reactions to a COVID-19 vaccine. Read More

Vanderbilt University faculty members Jane Landers, Alex Jahangir and Christopher Slobogin are scheduled to speak at “TEDxNashville: The End of Impossible” at the Schermerhorn Symphony Center Aug. 27–28. A limited number of free tickets are available, and Vanderbilt community members can get 25 percent off the price of individual general admission tickets to the event. Read More

A Vanderbilt research team has discovered that activation of a certain protein complex involved in the inflammatory response in immune cells contributes to salt-sensitive hypertension. Read More

A Thursday, Aug. 25, discussion will connect how childhood trauma impacts brain development and behavior, its intersection with the justice system, and how we can integrate this understanding in prevention, diversion and restorative efforts.   Read More

Vanderbilt researchers have developed an active machine learning approach to predict the effects of tumor variants of unknown significance, or VUS, on sensitivity to chemotherapy. Characterizing VUS can maximize clinical care and precision medicine for each patient. Read More

Nine graduate students in the School of Medicine Basic Sciences have been named recipients of the 2022 Dean’s Award for Exceptional Achievement in Graduate Studies. The students were recognized for the originality, significance and rigor of their dissertation research. Read More

Vanderbilt's Aspirnaut STEM pipeline for diversity and wellness recently celebrated its 15th anniversary with a daylong scientific symposium, followed by a feature on the Aug. 2 broadcast of NBC Nightly News. Read More

The Vanderbilt Kennedy Center recently introduced two brand-new educational resources created by the VKC’s Treatment and Research Institute for Autism Spectrum Disorders (TRIAD) and the Vanderbilt Consortium LEND Training Program. Read More

The American Academy of Nursing has selected four Vanderbilt School of Nursing faculty for its 2022 cohort of fellows. Read More

Vanderbilt study of 18,130 telehealth visits at the beginning of the COVID-19 pandemic defines risk factors associated with telehealth access and suggests how health systems can improve access. Read More

Just one-third of patients with relapsing multiple sclerosis remain on disease-modifying therapy, and specialty pharmacists are in a unique position to help coordinate therapy discontinuation or change and reduce the risk of relapse. Read More

A Vanderbilt study found that the bacterium Clostridioides difficile (C. difficile) may be a previously unrecognized contributor to colorectal cancer. Read More

Vanderbilt University School of Nursing is creating the Academy for Diverse Emerging Nurse Leaders, a leadership development program for nurses new to health care leadership and academic positions who are from groups historically underrepresented in nursing. Read More

A proposal to enhance wellness and resiliency training, led by RC Stabile, associate director for trainee wellbeing in the Office of Biomedical Research Education and Training, was recently awarded by the National Institute of General Medical Sciences. Read More

Researchers at Vanderbilt University Medical Center have discovered a potential new target in the fight against colorectal cancer, the nation’s third most common malignancy and, next to lung cancer, the second leading cancer killer. Read More

Vanderbilt researchers found that chronic use of opioid painkillers like hydrocodone and oxycodone significantly increases the risk of dysphagia, or difficulty swallowing. Read More

A collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine. The group used multiple single-cell technologies, unbiased machine learning and traditional immunological approaches to track cellular and antibody responses in samples collected over time from a cohort of healthy participants. Read More

Join Kendra Oliver, assistant professor of pharmacology and director and founder of ArtLab, for the next Lab-to-Table Conversation on Wednesday, July 27. The panelists will explore how a group of self-identified scientist-artists are embracing this particular duality.  Read More

Alyssa Hasty, Cornelius Vanderbilt Professor of Molecular Physiology and Biophysics, specializes in immunometabolism, specifically on the role that the immune system plays in obesity and metabolic disease. Recent work from her lab explored the changes in immune cell populations in fat during obesity, weight loss, and weight cycling. Read More